The association of intensity and overall level of physical activity energy expenditure with a marker of insulin resistance by Assah, F. K. et al.
ARTICLE
The association of intensity and overall level of physical
activity energy expenditure with a marker
of insulin resistance
F. K. Assah & S. Brage & U. Ekelund & N. J. Wareham
Received: 1 February 2008 /Accepted: 7 April 2008 /Published online: 17 May 2008
# The Author(s) 2008
Abstract
Aims/hypothesis Physical activity is important in prevent-
ing insulin resistance, but it is unclear which dimension of
activity confers this benefit. We examined the association
of overall level and intensity of physical activity with
fasting insulin level, a marker of insulin resistance.
Methods This was a cross-sectional analysis of the Medical
Research Council Ely population-based cohort study
(2000–2002). Physical activity energy expenditure (PAEE)
in kJ kg
−1 min
−1 was measured by heart rate monitoring
with individual calibration over a period of 4 days. The
percentage of time spent above 1.5, 1.75 and 2 times
resting heart rate (RHR) represented all light-to-vigorous,
moderate-to-vigorous and vigorous activity, respectively.
Results Data from a total of 643 non-diabetic individuals
(319 men, 324 women) aged 50 to 75 years were analysed.
In multivariate linear regression analyses, adjusting for age,
sex and body fat percentage, PAEE was significantly asso-
ciated with fasting insulin (pmol/l) (β=−0.875, p=0.006).
Time (% of total) spent above 1.75×RHR and also time
spent above 2×RHR were both significantly associated
with fasting insulin (β=−0.0109, p=0.007 and β=−0.0365,
p=0.001 respectively), after adjusting for PAEE, age, sex
and body fat percentage. Time spent above 1.5×RHR was
not significantly associated with fasting insulin in a similar
model (β=−0.0026, p=0.137).
Conclusions/interpretation The association between PAEE
and fasting insulin level, a marker of insulin resistance, may
be attributable to the time spent in moderate-to-vigorous
and vigorous activity, but not to time spent in light-intensity
physical activity.
Keywords Activityintensity.Energyexpenditure.
Insulin resistance.Physicalactivity
Abbreviations
bpm beats per min
CVD cardiovascular diseases
EE energy expenditure
HR heart rate
MET metabolic equivalent task
MRC Medical Research Council
PAEE physical activity energy expenditure
RHR resting heart rate
V
 CO2 carbon dioxide production
V
 O2 oxygen uptake
V
 O2max maximum oxygen uptake
Introduction
Cardiovascular disease (CVD) is now the leading cause of
morbidity and mortality both globally as well as in
industrialised countries [1, 2]. The increasing CVD burden
has been attributed to changing patterns of various lifestyle
and resulting aetiological risk factors such as physical
inactivity, obesity, glucose intolerance, dyslipidaemia and
high blood pressure [3, 4]. These risk factors cluster in
individuals in what has recently been termed the metabolic
or insulin resistance syndrome [5, 6]. Separately, these
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[7, 8], with the association greatly increasing when these
factors cluster together [9].
Insulin resistance, considered by some as one of the key
components of the metabolic syndrome, is an important
factor in the development of type 2 diabetes even in in-
dividuals with normal glucose tolerance [10–13]. It is also
associated with hypertension, dyslipidaemia and atheroscle-
rotic disease, coronary heart disease and stroke [14–16]. A
number of methods have been developed and validated for
use in evaluating insulin resistance in humans. The fasting
plasma insulin concentration, which is inexpensive and
relatively easy to measure, has been shown to be correlated
with insulin sensitivity measured by the clamp technique
[17, 18]. Fasting insulin has also been shown to identify
individuals with the metabolic syndrome [19] and to predict
future diabetes in non-diabetic individuals [17].
Several factors have been associated with the develop-
ment of insulin resistance, including age, obesity [20], body
fat distribution [21], dietary factors [22], genetic factors
[23], cardiorespiratory fitness and physical inactivity [24].
Previous research has shown that there is an inverse
association between physical activity and insulin resistance,
although most observational studies have used subjective
estimates of physical activity via self-report, some of which
only capture a specific dimension of activity such as
leisure-time or occupational physical activity [25, 26].
Fewer studies have used objective measures of physical
activity [8, 27], which may give a more reliable estimate of
physical activity patterns. A recent review of physical
activity and insulin resistance [28] highlighted major
uncertainties in our understanding of dose–response issues
and the subcomponents of activity most closely associated
with insulin sensitivity. These subcomponents relate to the
type of activity, volume, intensity, duration and frequency.
This is an important question, as it may contribute to the
design of appropriate preventive health strategies. In
particular, it is important to understand whether the asso-
ciation between insulin resistance and activity is explained
by total activity or by spending more time doing higher
intensity activities, since the consequence of such an
observation would be the development of very different
approaches to prevention.
We have previously observed associations between phys-
ical activity energy expenditure (PAEE) and fasting insulin
level [23, 29], a marker of insulin resistance, and between
PAEE and clustered metabolic risk [30, 31]. We did not,
however, examine the impact of the intensity of physical
activity on these associations. Therefore, the aim of the
present study was to examine the association of overall
level and intensity of physical activity with fasting insulin
level in a cross-sectional analysis of the Medical Research
Council (MRC) Ely cohort study.
Methods
Participants The participants for this study were all part of
the MRC Ely study, a prospective population-based cohort
study of the aetiology and pathogenesis of type 2 diabetes
and related metabolic disorders [10, 32]. The present cross-
sectional analyses were performed using data from the
second follow up (2000–2002).
A total of 678 individuals from the cohort, for whom
complete data on free-living heart rate (HR) monitoring
were available and who did not have previously diagnosed
diabetes, were included in the present report. Based on a
75 g oral glucose tolerance test, the participants were
classified according to the 1998 WHO glucose tolerance
categories [5] into normal glucose, impaired fasting
glucose, impaired glucose tolerance or diabetes. A total of
20 individuals were diagnosed as having type 2 diabetes, 12
did not provide a 2 h glucose measurement and three
individuals had no data on fasting insulin; all of these were
excluded. Thus, the present analyses include 643 individ-
uals (319 men, 324 women). Ethical approval for the MRC
Ely cohort study was obtained from the Cambridge local
research ethics committee and all participants provided
signed informed consent.
Physical activity Physical activity was objectively mea-
sured by HR monitoring. PAEE was assessed using the flex
HR method with individual calibration of the HR–energy
expenditure (EE) relationship using indirect calorimetry
[33] during rest and submaximal exercise as previously
described [34, 35]. Briefly, resting oxygen uptake ðV
  O2Þ
and carbon dioxide productionðV
 CO2Þ were measured in
a supine position for at least 6 min. Heart rate (in beats per
minute, bpm),V
 O2 and V
 CO2 were then assessed during an
incremental treadmill exercise protocol. The protocol com-
prised 5-min stages of walking, starting at 4.0 km/h and 0%
gradient, then increasing to 5% gradient, 10% gradient
(4.0 km/h) and finally 5.6 km/h at 10% gradient. V
 O2 and
V
 CO2 were continuously measured throughout the test
(Vista XT metabolic system; Vacumed, Ventura, CA, USA).
Participants breathed through a facemask (Hans Rudolph,
Kansas City, MO, USA) and expired air was measured with
a turbine flowmeter, carbon dioxide concentration with an
infrared sensor and oxygen concentration with a fast
differential paramagnetic sensor. Flow-rate, carbon dioxide
concentration and oxygen concentration data were analysed
with Vista Turbofit software (Vacumed) to calculate V
 O2
and V
  CO2. Gas analysers were calibrated with gases of
known composition and the turbine flowmeter was cali-
brated with a 3 l syringe before each measurement.
At any point of the test, the procedure was stopped if (1)
the individual’s HR exceeded 90% of age-predicted
maximum HR (220—age); (2) the individual’s HR exceeded
1400 Diabetologia (2008) 51:1399–140780% of maximum HR for over 2 min; or (3) the individual
developed breathlessness, chest pain or symptoms of
presyncope, or (4) he or she asked to stop.
The flex HR point was calculated as the mean of the
highest HR during rest and the lowest HR during exercise.
Resting HR (RHR) was calculated as the average of the
individual HR data points during supine rest.
Free-living HR (Polar Electro, Kempele, Finland) was
measured on a minute-by-minute basis during the waking
hours over 4 days. Data from the individual calibration
were used to predict minute-by-minute EE for each
participant [36]. PAEE was calculated by subtracting mean
resting EE from average EE (expressed in kJ kg
−1 min
−1).
The individual minute-by-minute HR data were pro-
cessed after categorising into bands of 1.5 to 1.75, 1.75 to
2.0 and above 2.0×RHR, and then collapsed into bands of
time spent above 1.5×RHR, above 1.75×RHR and above
2.0×RHR. These time-estimates were expressed as a
percentage of the total number of free-living data points.
Internally, we compared these intensity categories against
intensity categories from accelerometry (Actigraph; MTI,
Fort Walton Beach, FL, USA) in an independent sample of
adults (n=265). Accelerometer counts of 101–1951, 1952–
5723 and above 5723 counts/minute were considered as
light, moderate and rigorous intensity activities respectively.
The mean difference in percentage of time spent in activity
between HR monitoring (above 1.5 RHR) and accelerometry
was 3.19% (95% CI 0.14–6.25). The mean difference in time
spent in moderate-to-vigorous and vigorous activity between
the two methods was 2.37% (95% CI 1.41–3.34) and 0.88%
(95% CI 0.66–1.11) respectively. Time spent at 1.5 to
1.75 RHR was weakly significantly correlated with time
spent at light intensity activity from accelerometry (r=0.14,
p=0.043). Time spent at 1.75 to 2.0 RHR and time spent
above 2.0 RHR were significantly correlated with time
spent at moderate and vigorous activity from accelerometry,
respectively (r=0.31, p<0.0001; r=0.45, p<0.0001).
In the present aetiological analyses, three time estimates
were considered: time spent above 1.5×RHR, above 1.75×
RHR and above 2.0×RHR. The reasoning behind this was
that these categorisations would have clinical utility without
the need for expensive equipment.
Cardiorespiratory fitness An estimate of aerobic fitness was
obtained by linear extrapolation of the individually observed
HR–V
  O2 relationship up to age-predicted maximum HR.
Fasting insulin All participants were asked to refrain from
eatinganddrinkingfrom22:00hoursonthepreviousevening
and fasting blood samples were collected between 08:30 and
09:30 hours on the next day. The plasma samples were
immediately separated in a cooled centrifuge at 4°C. After
centrifugation (∼1,400×g), the plasma samples were divided
into aliquots, placed in the freezer at −20°C, then packed in
dry ice and transported to the biochemistry laboratory where
they were stored at −70°C within 4 h of collection. Plasma
insulin was measured by two-site immunometric assays with
either
125I or alkaline phosphatase labels. Cross-reactivity
was <0.2% with intact proinsulin at 400 pmol/l and <1%
with 32–33 split proinsulin at 400 pmol/l. Inter-assay CVs
were 6.6% at 28.6 pmol/l (n=99), 4.8% at 153.1 pmol/l
(n= 102) and 6.0% at 436.7 pmol/l (n=99) respectively.
Anthropometry Height without shoes was measured using a
standard rigid stadiometer. Body weight was measured
using standard calibrated clinical weight scales in light
clothes to the nearest 0.1 kg.
Waist and hip circumferences were measured using a D-
loop non-stretch fibreglass tape measure with participants in
lightindoor clothing. The waist circumferencewasmeasured
at the mid-point between the lower costal margin and the
level of the anterior superior iliac crests. The hip circumfer-
encewas measured atthelevel ofthegreatertrochanters.The
circumferences were measured in cm to the nearest 0.1 cm.
Body composition was assessed by impedance using a
standard bioimpedance technique (Bodystat 1500; Bodystat,
IsleofMan,UK)accordingtothemanufacturer’sinst ructio ns.
This method has previously been shown to be valid [37].
Statistical analyses Analyses were done using STATA
version 9.2 SE software (StataCorp, College Station, Texas,
USA). Baseline descriptive characteristics of the study
participants are presented as means with standard devia-
tions or as numbers with proportions and are stratified by
sex and/or age groups. The distribution of fasting insulin
concentration was right-skewed and therefore normalised
by logarithmic transformation. The central tendency was
reported as geometric mean with 95% CIs.
The association between the distribution of physical
activity intensity and PAEE was explored first by examin-
ing the correlation between PAEE and time spent in the
different HR zones, and second by stratifying PAEE into
quartiles and using one-way ANOVA to test for differences
between these quartiles of the time spent in the HR zones.
In the multivariate linear regression models, the effect of
PAEE (entered as a continuous variable) on log fasting
insulin was explored with adjustment for age and sex, both
with and without adjustment for body fat percentage. To
these two models, we then added the time spent in each of
the RHR zones in turn.
Results
Characteristics of the participants A total of 643 individ-
uals (319 men, 324 women) for whom data on percentage
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included in these analyses. The characteristics of the study
population are presented in Table 1, stratified by sex. There
was no significant difference in the mean age by sex. Men
reported a higher prevalence of alcohol consumption and
smoking than women (80.5 vs 73% and 14.4 vs 12.2%
respectively). On average, men were heavier than women
and had a larger waist circumference and WHR, whereas
body fat percentage was higher in women. Some 50% of
men and 38% of women were overweight (BMI≥25 and
<30 kg/m
2) while 19 and 18% respectively were obese
(BMI≥30 kg/m
2).
A total of 12% of women compared with 16% of men
had impaired glucose tolerance. Women on average had a
significantly lower fasting insulin level than men (47.7 vs
57.9 pmol/l; p<0.001). Total EE and PAEE were signifi-
c a n t l yh i g h e ri nm e nt h a ni nw o m e n( p<0.001), a
difference that persisted after normalising PAEE by body
weight.
The mean (±SD) flex HR was 81±11 bpm or on average
1.2×RHR. Flex HR was almost always lower than 1.5×
RHR (in 98% of the individuals). RHR was significantly
negatively correlated with cardiorespiratory fitness (r=
−0.4, p<0.001). The mean resting energy expenditure was
0.09±0.02 kJ kg
−1 min
−1 (1.3 metabolic equivalents
[MET]) and the energy expenditure corresponding to the
three HR thresholds of 1.5, 1.75 and 2×RHR was 0.35±
0.08, 0.46±0.1, and 0.56±0.13 kJ kg
−1 min
−1 (or 4.9, 6.5,
and 7.9 MET) respectively. Table 2 presents data, stratified
by sex, on the distribution of physical activity intensity as
percentage of time spent at HR zones 1.5 to 1.75, 1.75 to
2.0 and above 2.0×RHR. Men generally spent more time
than women in each of the three HR zones considered
(p<0.01). Both men and women spent on average (±SD)
14.7% (±13.9%) of their waking hours above 1.5×RHR.
Median (interquartile range) time spent above 1.75 RHR
was 1.3% (0.2–4.4%) and that spent above 2×RHR was
0.1% (0–0.6%).
Associations between fasting insulin, PAEE and activity
intensity PAEE was significantly correlated with the per-
centage of time spent above 1.5×RHR (r=0.61, p<0.001),
above 1.75×RHR (r=0.49, p<0.001), and above 2×RHR
(r=0.35, p<0.001). Figure 1 shows that there was a trend
towards a decreasing fasting insulin level across sex-
specific quartiles of PAEE, from the first quartile to the
fourth. A similar tendency was seen for sex-specific
quartiles of time spent above 1.75×RHR and above 2.0×
RHR, but not for time spent above 1.5×RHR.
The results of the linear regression analyses of log
fasting insulin and PAEE are presented in various models in
Table 3. Since the direction of association of the initial
analyses was the same for men and women, all remaining
analyses are presented in the entire population after
adjustment for sex. PAEE was significantly negatively
associated with log fasting insulin in an unadjusted model
(β=−1.15, p<0.001). In multivariate regression adjusting
for age and sex, and then including body fat percentage
(models 1 and 2), the association of log fasting insulin with
PAEE remained highly statistically significant (β=−1.87,
p<0.001 and β=−0.875, p=0.006 respectively). In the
latter model, log fasting insulin was significantly positively
associated with body fat percentage and negatively associ-
ated with being a woman (p<0.001).
The effect of time spent at different HR zones on the
association between PAEE and log fasting insulin was
investigated by including these HR zones individually in
models 1 and 2. The introduction of time spent above 1.5×
RHR into model 2 (model 2a) attenuated the association
between PAEE and log fasting insulin, and in this model
neither PAEE (β=−0.532, p=0.173) nor time spent above
1.5×RHR (β=−0.003, p=0.137) was significant after
Table 1 Baseline characteristics by sex; the MRC Ely Study, 2000–2002
Men (n=319) Women (n=324)
Mean SD Range Mean SD Range
Age (years) 57.9 4.6 50.2–75.0 57.5 4.0 50.1–73.8
Weight (kg) 84.0 12.8 55–131 69.9 13.1 45–126.5
BMI (kg/m
2) 27.1 3.8 18.5–40.8 26.4 4.6 17.8–46.3
WHR 0.94 0.06 0.80–1.11 0.81 0.06 0.59–1.02
Body fat (%) 25.2 4.8 7.3–44.5 37.8 5.9 20.4–56.4
FPG (mmol/l) 4.7 0.6 3.7–6.9 4.4 0.5 3.4–6.6
Fasting insulin (pmol/l) 57.9 32.3 8.0–249.0 47.7 30.6 4.9–261.0
Fitness (ml kg
−1 min
−1) 43.5 9.1 23.3–84.5 34.8 9.1 3.5–78.8
PAEE (kJ kg
−1 min
−1 ) 0.14 0.07 0–0.33 0.09 0.06 0–0.30
Participants: n=643
FPG, fasting plasma glucose
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model 2b, where time spent above 1.75×RHR was
introduced into model 2, the observed negative association
between PAEE and log fasting insulin was attenuated (β=
−0.454, p=0.195). After adjustment for PAEE, age, sex and
body fat percentage, we saw a statistically significant
negative association between time spent above 1.75×RHR
and log fasting insulin (β=−0.011, p=0.007). The inclusion
of time spent above 2×RHR also attenuated the association
between log fasting insulin and PAEE (β=−0.56, p=0.087).
Furthermore, time spent above 2×RHR (model 2c) was
significantly negatively associated with log fasting insulin
(β=−0.037, p=0.001) after adjusting for PAEE and the
same confounders as above. The explained variance in log
fasting insulin varied between 8 and 10% for the models
excluding body fat percentage (models 1, 1a, 1b and 1c)
and between 26 and 28% for the models that included body
fat percentage (models 2, 2a, 2b, 2c).
Finally, we re-examined all associations with further
adjustment for aerobic fitness, and also substituted body fat
percentage by waist circumference as a confounding factor;
the results remained unchanged (data not shown).
Discussion
This study investigated the association between objectively
measured PAEE and fasting insulin level as a measure of
insulin resistance, specifically exploring the effect of
physical activity intensity using a simple RHR-derived
definition on the observed association. PAEE was signifi-
cantly and inversely associated with fasting insulin inde-
pendently of sex, age and body fat. However, this
association was mainly explained by an association of
moderate and vigorous physical activity with fasting
insulin.
Table 2 Proportion of time spent in different RHR zones (%) during free-living; the MRC Ely Study, 2000–2002
Percentage of time spent
n
a Median Range Mean SD
Men (n=319)
1.5–1.75 RHR 314 9.6 0–50.1 12.0 9.9
1.75–2 RHR 282 1.6 0–25.6 3.4 4.6
>2 RHR 202 0.1 0–16.5 1.1 2.3
Women (n=324)
1.5–1.75 RHR 319 8.2 0–50.5 10.4 9.2
1.75–2 RHR 276 0.8 0–26.4 2.1 3.1
>2 RHR 184 0.1 0–11.4 0.5 1.3
Participants: n=643
an=number of individuals with non-zero values
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Fig. 1 Mean (95% CI) fasting insulin by sex-specific quartiles of PAEE (a) and percentage time spent at different RHR zones as indicated (b–d).
Dark grey bars, men; light grey bars, women. The MRC Ely Study, 2000–2002. n=643
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gesting that physical activity is negatively associated with
fasting insulin level. Many of these studies have been based
on subjective reports of physical activity using diaries or
questionnaires with very different methodologies [38–40].
Some of these studies only assessed a specific category of
activity such as occupational or leisure-time activity, but
not the total amount or intensity of activity. A few other
studies have used objective methods of measuring physical
activity, including doubly-labelled water [8, 27], indirect
calorimetry [27], accelerometers [8, 30, 31], and HR
monitoring [23, 29]. Dvorak et al [27], using the doubly-
labelled water method, found no significant association
between PAEE and fasting insulin. This could be due to
the fact that they did not correct PAEE for differences in
body size or adjust for body weight in their analyses.
This is a cross-sectional study, limiting inferences of
causality and its direction. However, it has been shown that
physicallyactivemenwerelesslikelytodevelopthemetabolic
syndromethansedentarymen[41, 42] and that PAEE predicts
progression towards the metabolic syndrome [43]. Moreover,
data from trials have demonstrated that physical activity leads
to improved insulin sensitivity or reduced insulin resistance
[44, 45]. A previous randomised controlled trial reported on
the effect of interventions based on activity intensity and
volume (three groups + control) on insulin resistance/insulin
sensitivity in participants with normal glucose tolerance [44].
That study suggested that fasting insulin increased signifi-
cantly in the control group and decreased in the low-volume/
moderate-intensity and high-volume/high-intensity groups,
whereas the decrease in the low-volume/high-intensity group
was not statistically significant. The authors concluded that
weekly exercise duration was an important variable influenc-
ing changes in insulin sensitivity. These findings are similar
to ours, showing that increase in overall physical activity
results in a decrease in fasting insulin, even though in that
study, the intensity of the exercise training did not signifi-
cantly influence insulin sensitivity.
Table 3 Independent associations between physical activity intensity and insulin resistance; the MRC Ely Study, 2000–2002
β tp value R
2
Model 1 0.0819
PAEE (kJ kg
−1 min
−1) −1.8701 −5.53 <0.001
Age (years) 0.0003 0.06 0.95
Sex (female) −0.2981 −6.59 <0.001
Model 1a 0.083
PAEE (kJ kg
−1 min
−1) −1.6504 −3.91 <0.001
Time above 1.5 RHR (%) −0.0017 −0.87 0.385
Model 1b 0.0914
PAEE (kJ kg
−1 min
−1) −1.42 −3.74 <0.001
Time above 1.75 RHR (%) −0.0116 −2.57 0.01
Model 1c 0.0991
PAEE (kJ kg
−1 min
−1) −1.4882 −4.22 <0.001
Time above 2 RHR (%) −0.0427 −3.49 0.001
Model 2 0.2626
PAEE (kJ kg
−1 min
−1) −0.875 −2.78 0.006
Age (years) −0.0065 −1.44 0.151
Sex (female) −0.8471 −14.15 <0.001
Body fat (%) 0.0466 12.45 <0.001
Model 2a 0.2651
PAEE (kJ kg
−1 min
−1) −0.5319 −1.36 0.173
Time above 1.5 RHR (%) −0.0026 −1.49 0.137
Model 2b 0.2709
PAEE (kJ kg
−1 min
−1) −0.4535 −1.3 0.195
Time above 1.75 RHR (%) −0.0109 −2.7 0.007
Model 2c 0.2751
PAEE (kJ kg
−1 min
−1) −0.5598 −1.72 0.087
Time above 2 RHR (%) −0.0365 −3.32 0.001
Participants: n=643
β is the regression coefficient (log pmol/l per unit increase in exposure)
t is the t statistic which corresponds to the regression coefficient divided by its standard error
Models 1, 1a, 1b and 1c are adjusted for age and sex
Models 2, 2a, 2b and 2c are adjusted for age, sex and body fat percentage
1404 Diabetologia (2008) 51:1399–1407Different biological mechanisms have been proposed
through which physical activity exerts its action on insulin
resistance [28]. These mechanisms include the upregulation
of the rate-limiting enzymes of glycolysis and proteins in
the insulin-signalling cascade, the lowering of triacylgly-
cerol and NEFA, stimulated endothelial release of nitric
oxide and the modulation of appetite via the leptin pathway.
Acute muscle contraction allocates glucose transporter-4 to
the cell membrane through an insulin-independent mecha-
nism. This acute effect makes it difficult to investigate the
effect of physical activity on insulin sensitivity or glucose
transport, since observations could be attributable to the
most recent bout of activity rather than to a chronic effect.
Collinearity between PAEE and time spent above 1.5,
1.75 and 2.0×RHR could be a possible reason for the
attenuation of the association between fasting insulin and
PAEE when HR zone variables were included in the model.
This is unlikely since in the multivariate regression models,
no substantial increase in the standard error of the coefficient
of PAEE was seen when time spent at 1.5 to 1.75, 1.75 to 2.0
or above 2.0×RHR was individually added to the model,
which would have indicated collinearity [46].
After adjusting for age, sex, body composition and
PAEE, percentage time spent above 1.75×RHR and above
2×RHR was inversely associated with fasting insulin. This
means that moderate-to-vigorous (above 1.75×RHR) and
vigorous (above 2.0×RHR) activity were inversely associ-
ated with fasting insulin independently of PAEE. In
contrast, light physical activity was not independently
associated with fasting insulin. This may mean that
moderate-to-vigorous physical activity is more important
than light-intensity activity in relation to insulin resistance,
although we acknowledge that light activity may be
measured with a greater degree of error than moderate
and vigorous activity. We note that intensity of activity in
this context should be interpreted as relative intensity, due
to the normalising effect of RHR and the strong correlation
between cardiorespiratory fitness and RHR. This also
explains the robustness of our results to additional
adjustment for fitness and stresses the clinical utility of
this simple measure of physical activity intensity.
Due to the moderate sample size of this study and the
consistency of the associations reported, chance alone is
unlikely to explain the observed associations. The individ-
uals in this study are part of the MRC Ely cohort study [10,
32], which is an ongoing population-based cohort study.
These participants are a subgroup of the initial volunteers
who have been followed up, and includes particularly those
who participated in the calibration test procedure. This
means that there is a possible healthy sample selection bias.
This bias could limit the generalisability of these findings to
other populations and maybe to the target population, but it
should not affect the internal validity of the associations
observed. This population sample was, however, similar to
the general population of England in terms of the
prevalence of overweight and obesity, which are major risk
factors for insulin resistance. The prevalence of overweight
and obesity in this sample was 69% in men and 56% in
women, and is similar to the national rates of 68% in men
and 56% in women [47].
The effects of potential confounders were considered in
the analyses. In the descriptive analyses, the results are
presented stratified by sex [48, 49]. In the multivariate
regression models, adjustments were made for age, sex and
body composition when exploring the association between
PAEE and fasting insulin. In addition, PAEE was included
in the model as a covariate (confounder or mediator), when
the effect of intensity of activity on fasting insulin was
analysed, implying that the observed associations between
different activity intensities and fasting insulin was inde-
pendent of overall activity. However, insulin resistance is a
multifactorial phenotype involving many other factors. Our
multivariate models explained between 26 and 28% of the
total variance of fasting insulin, with the physical activity
variables accounting for 2 to 3% of the total variance.
In these analyses, the proportion of total awake hours spent
in HR zones 1.5 to 1.75, 1.75 to 2.0 and above 2.0×RHR was
used as proxy for light, moderate and vigorous activity,
respectively. The use of individual RHR in the calculation of
time spent at the specified HR zones takes into account
between-individual differences in aerobic fitness, and as HR
monitors are widely available, our results may be more
meaningful at the consumer level and in clinical practice
than results based on intensity in units of body movement
and energy per time as assessed by more cumbersome
procedures (e.g. accelerometry or indirect calorimetry).
In conclusion, this study has provided further evidence
of the benefits of physical activity on fasting insulin levels,
a measure of insulin resistance. We have previously
reported that physical activity is inversely associated with
fasting insulin, even after adjustments for age, sex and body
composition [23, 29]. However, the results of the present
study suggest that the beneficial effect of PAEE on fasting
insulin level may be attributable to the time spent in
moderate and vigorous activity and not so much to the time
spent on light intensity activity. Public health strategies to
reduce insulin resistance in middle-aged individuals could
therefore encourage people to increase their overall PAEE
by devoting more time to moderate and perhaps even
vigorous activities.
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